Price to Book Value (P/BV)
since 2005
Calculation
Gilead Sciences Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Gilead stockholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | 4.01 | = | 73.55 | ÷ | 18.33 | 18.33 | = | 22,833 | ÷ | 1,245,774,616 | |
| Feb 22, 2023 | 4.90 | = | 83.50 | ÷ | 17.03 | 17.03 | = | 21,240 | ÷ | 1,247,105,154 | |
| Feb 23, 2022 | 3.65 | = | 61.35 | ÷ | 16.80 | 16.80 | = | 21,069 | ÷ | 1,253,886,724 | |
| Feb 25, 2021 | 4.33 | = | 62.79 | ÷ | 14.49 | 14.49 | = | 18,202 | ÷ | 1,256,593,156 | |
| Feb 25, 2020 | 3.93 | = | 70.10 | ÷ | 17.83 | 17.83 | = | 22,525 | ÷ | 1,263,636,656 | |
| Feb 26, 2019 | 3.89 | = | 65.28 | ÷ | 16.77 | 16.77 | = | 21,387 | ÷ | 1,275,510,558 | |
| Feb 27, 2018 | 5.15 | = | 80.36 | ÷ | 15.60 | 15.60 | = | 20,442 | ÷ | 1,309,967,781 | |
| Feb 27, 2017 | 4.88 | = | 70.50 | ÷ | 14.45 | 14.45 | = | 18,887 | ÷ | 1,307,066,900 | |
| Feb 24, 2016 | 6.59 | = | 89.36 | ÷ | 13.56 | 13.56 | = | 18,534 | ÷ | 1,366,845,691 | |
| Feb 25, 2015 | 10.08 | = | 104.43 | ÷ | 10.36 | 10.36 | = | 15,426 | ÷ | 1,489,401,683 | |
| Feb 25, 2014 | 11.36 | = | 83.95 | ÷ | 7.39 | 7.39 | = | 11,369 | ÷ | 1,538,252,914 | |
| Feb 27, 2013 | 7.01 | = | 42.89 | ÷ | 6.12 | 6.12 | = | 9,310 | ÷ | 1,522,392,518 | |
| Feb 23, 2012 | 5.08 | = | 22.58 | ÷ | 4.45 | 4.45 | = | 6,739 | ÷ | 1,514,630,722 | |
| Feb 28, 2011 | 5.29 | = | 19.49 | ÷ | 3.69 | 3.69 | = | 5,864 | ÷ | 1,590,529,288 | |
| Mar 1, 2010 | 6.74 | = | 23.76 | ÷ | 3.52 | 3.52 | = | 6,367 | ÷ | 1,806,757,972 | |
| Feb 27, 2009 | 9.83 | = | 22.40 | ÷ | 2.28 | 2.28 | = | 4,152 | ÷ | 1,821,909,204 | |
| Feb 27, 2008 | 11.76 | = | 21.90 | ÷ | 1.86 | 1.86 | = | 3,460 | ÷ | 1,857,740,064 | |
| Feb 27, 2007 | 18.07 | = | 17.65 | ÷ | 0.98 | 0.98 | = | 1,816 | ÷ | 1,858,655,664 | |
| Mar 3, 2006 | 9.18 | = | 15.03 | ÷ | 1.64 | 1.64 | = | 3,028 | ÷ | 1,849,138,544 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Gilead Sciences Inc. Annual Report.
Comparison to Competitors
Gilead Sciences Inc., P/BV, long-term trends, comparison to competitors
| Gilead Sciences Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | 4.01 | 29.97 | 24.94 | 3.35 | 3.47 | 65.80 | 5.48 | 8.68 | 2.66 | 1.75 | 3.96 | 4.57 |
| Feb 22, 2023 | 4.90 | 15.52 | 35.01 | 4.88 | 3.64 | 29.36 | 5.37 | 6.07 | 2.81 | 2.48 | 3.77 | 4.83 |
| Feb 23, 2022 | 3.65 | 16.53 | 18.51 | 4.07 | 4.16 | 25.28 | 5.90 | 5.05 | 4.31 | 3.35 | 3.60 | 5.18 |
| Feb 25, 2021 | 4.33 | 14.18 | 14.53 | 3.55 | 3.93 | 35.07 | 6.72 | 7.46 | 24.16 | 2.98 | 4.81 | 5.15 |
| Feb 25, 2020 | 3.93 | — | 13.84 | 2.80 | 3.72 | 51.67 | 6.61 | 7.83 | 8.21 | 3.00 | 3.79 | 4.16 |
| Feb 26, 2019 | 3.89 | — | 9.41 | 5.89 | 2.80 | 12.87 | 6.08 | 7.79 | 4.29 | 3.80 | 5.07 | 3.75 |
| Feb 27, 2018 | 5.15 | 36.95 | 5.02 | 8.88 | 2.58 | 7.33 | 5.79 | 4.30 | — | 2.94 | 5.66 | 3.30 |
| Feb 27, 2017 | 4.88 | 21.24 | 4.14 | 5.66 | 2.56 | 6.33 | 4.72 | 4.51 | — | 3.40 | 8.58 | 2.86 |
| Feb 24, 2016 | 6.59 | 22.17 | 3.94 | 7.04 | 2.53 | 5.51 | 4.07 | 3.15 | — | 2.84 | 10.53 | 2.42 |
| Feb 25, 2015 | 10.08 | 56.09 | 4.59 | 6.72 | 2.63 | 5.14 | 4.01 | 3.42 | — | 2.95 | 16.22 | 2.51 |
| Feb 25, 2014 | 11.36 | 18.05 | 4.30 | 5.92 | 2.38 | 3.69 | 3.50 | 3.35 | — | 2.69 | 16.74 | 2.90 |
| Feb 27, 2013 | 7.01 | 18.06 | 3.57 | 4.40 | 2.23 | 4.15 | 3.29 | 2.44 | — | 2.42 | 12.91 | 1.72 |
| Feb 23, 2012 | 5.08 | — | 2.83 | 3.50 | 2.17 | 3.35 | 3.13 | 2.14 | — | 1.95 | 19.19 | 1.38 |
| Feb 28, 2011 | 5.29 | — | 2.04 | 2.76 | 2.39 | 3.21 | 2.88 | 1.85 | — | 1.75 | 6.42 | 1.41 |
| Mar 1, 2010 | 6.74 | — | 2.46 | 2.88 | 2.07 | 4.17 | 3.45 | 1.97 | — | 1.57 | 5.49 | 1.29 |
| Feb 27, 2009 | 9.83 | — | 2.48 | 3.29 | 1.69 | 5.01 | 3.56 | 2.72 | — | 1.44 | 2.94 | 1.02 |
| Feb 27, 2008 | 11.76 | — | 2.77 | 4.22 | 2.62 | 4.16 | 4.17 | 5.38 | — | 2.32 | 3.24 | 1.62 |
| Feb 27, 2007 | 18.07 | — | 3.96 | 5.50 | 3.32 | 5.43 | 4.78 | 5.45 | — | 2.49 | 5.77 | 1.38 |
| Mar 3, 2006 | 9.18 | — | 4.26 | 4.00 | 3.78 | 5.85 | 4.66 | 4.30 | — | 2.94 | 8.16 | 2.03 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Gilead Sciences Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Gilead Sciences Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 23, 2024 | 4.01 | 6.66 |
| Feb 22, 2023 | 4.90 | 5.54 |
| Feb 23, 2022 | 3.65 | 5.66 |
| Feb 25, 2021 | 4.33 | 6.13 |
| Feb 25, 2020 | 3.93 | 5.74 |
| Feb 26, 2019 | 3.89 | 5.93 |
| Feb 27, 2018 | 5.15 | 5.04 |
| Feb 27, 2017 | 4.88 | 4.52 |
| Feb 24, 2016 | 6.59 | 4.10 |
| Feb 25, 2015 | 10.08 | 4.40 |
| Feb 25, 2014 | 11.36 | 3.93 |
| Feb 27, 2013 | 7.01 | 3.19 |
| Feb 23, 2012 | 5.08 | 2.53 |
| Feb 28, 2011 | 5.29 | 2.23 |
| Mar 1, 2010 | 6.74 | 2.35 |
| Feb 27, 2009 | 9.83 | 2.58 |
| Feb 27, 2008 | 11.76 | 3.41 |
| Feb 27, 2007 | 18.07 | 3.81 |
| Mar 3, 2006 | 9.18 | 3.98 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Gilead Sciences Inc., P/BV, long-term trends, comparison to industry (health care)
| Gilead Sciences Inc. | Health Care | |
|---|---|---|
| Feb 23, 2024 | 4.01 | 5.13 |
| Feb 22, 2023 | 4.90 | 71,951.01 |
| Feb 23, 2022 | 3.65 | 4.78 |
| Feb 25, 2021 | 4.33 | 4.66 |
| Feb 25, 2020 | 3.93 | 4.41 |
| Feb 26, 2019 | 3.89 | 4.42 |
| Feb 27, 2018 | 5.15 | 4.25 |
| Feb 27, 2017 | 4.88 | 3.83 |
| Feb 24, 2016 | 6.59 | 3.47 |
| Feb 25, 2015 | 10.08 | 3.90 |
| Feb 25, 2014 | 11.36 | 3.30 |
| Feb 27, 2013 | 7.01 | 2.70 |
| Feb 23, 2012 | 5.08 | 2.38 |
| Feb 28, 2011 | 5.29 | 2.11 |
| Mar 1, 2010 | 6.74 | 2.23 |
| Feb 27, 2009 | 9.83 | 2.42 |
| Feb 27, 2008 | 11.76 | 3.26 |
| Feb 27, 2007 | 18.07 | 3.75 |
| Mar 3, 2006 | 9.18 | 3.89 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).